PHARMACYTE BIOTECH, INC.: 10-Q filed 2013-03-26

Name: PHARMACYTE BIOTECH, INC.: 10-Q filed 2013-03-26
Creator: PHARMACYTE BIOTECH, INC.

What PHARMACYTE BIOTECH, INC. reported in its quarterly report filed 2013-03-26 (fiscal Q3 2013): 33 published measures, 91 facts as tagged in accession 0001445305-13-000706.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-03-26
Fiscal period: fiscal Q3 2013
Accession: 0001445305-13-000706 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHARMACYTE BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-01-31	2,450,946	USD
At 2012-04-30	2,087,508	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-01-31	3,900,275	USD
At 2012-04-30	3,787,358	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2013-01-31	-2,029,329	USD
At 2012-04-30	-2,279,850	USD
At 2011-04-30	-2,729,293	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-01-31	33,334	USD
At 2012-04-30	15,723	USD
At 2012-01-31	39,077	USD
At 2011-04-30	57,201	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	-376,843	USD	92
2012-05-01 to 2013-01-31	-1,270,929	USD	276
2011-05-01 to 2012-04-30	-1,899,312	USD	366
2011-11-01 to 2012-01-31	-271,779	USD	92
2011-05-01 to 2012-01-31	-1,394,949	USD	276

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	-247,475	USD	276
2011-05-01 to 2012-01-31	-207,334	USD	276

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	0	USD	92
2012-05-01 to 2013-01-31	12,160	USD	276
2011-11-01 to 2012-01-31	20,271	USD	92
2011-05-01 to 2012-01-31	59,877	USD	276

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	746,836	USD	276
2011-05-01 to 2012-01-31	869,210	USD	276

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	-481,750	USD	276
2011-05-01 to 2012-01-31	-680,000	USD	276

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-01-31	-41,118,934	USD
At 2012-04-30	-39,848,005	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	444,680,028	shares	92
2012-05-01 to 2013-01-31	433,008,706	shares	276
2011-11-01 to 2012-01-31	373,337,581	shares	92
2011-05-01 to 2012-01-31	371,867,725	shares	276

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2012-11-01 to 2013-01-31	USD/shares	92
2012-05-01 to 2013-01-31	USD/shares	276
2011-11-01 to 2012-01-31	USD/shares	92
2011-05-01 to 2012-01-31	USD/shares	276

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	635,396	USD	276
2011-05-01 to 2012-01-31	1,252,453	USD	276

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	-340,840	USD	92
2012-05-01 to 2013-01-31	-1,229,175	USD	276
2011-11-01 to 2012-01-31	-409,983	USD	92
2011-05-01 to 2012-01-31	-1,466,312	USD	276

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-01-31	1,422,168	USD
At 2012-04-30	1,058,730	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	3,982	USD	92
2012-05-01 to 2013-01-31	117,312	USD	276
2011-11-01 to 2012-01-31	35,756	USD	92
2011-05-01 to 2012-01-31	102,597	USD	276

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-01-31	3,608,275	USD
At 2012-04-30	3,787,358	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-01-31	517,394	USD
At 2012-04-30	730,068	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	340,840	USD	92
2012-05-01 to 2013-01-31	1,231,715	USD	276
2011-11-01 to 2012-01-31	428,043	USD	92
2011-05-01 to 2012-01-31	1,502,267	USD	276

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2013-01-31	0	USD
At 2012-04-30	6,846	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	0	USD	92
2012-05-01 to 2013-01-31	2,540	USD	276
2011-11-01 to 2012-01-31	18,060	USD	92
2011-05-01 to 2012-01-31	35,955	USD	276

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	9,620	USD	276
2011-11-01 to 2012-01-31	2,211	USD	92
2011-05-01 to 2012-01-31	23,922	USD	276

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-01-31	457,942,825	shares
At 2012-04-30	416,293,195	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-01-31	39,043,811	USD
At 2012-04-30	37,526,524	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-01-31	11,900	USD
At 2012-04-30	407,463	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-01-31	32,854	USD
At 2012-04-30	159,350	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	120,910	USD	92
2012-05-01 to 2013-01-31	418,548	USD	276
2011-11-01 to 2012-01-31	40,095	USD	92
2011-05-01 to 2012-01-31	289,147	USD	276

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	0	USD	276
2011-05-01 to 2012-04-30	24,659	USD	366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2012-11-01 to 2013-01-31	-36,003	USD	92
2012-05-01 to 2013-01-31	-41,754	USD	276
2011-11-01 to 2012-01-31	138,204	USD	92
2011-05-01 to 2012-01-31	71,363	USD	276

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	685,325	USD	276
2011-05-01 to 2012-01-31	621,000	USD	276

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	-2,581	USD	276
2011-05-01 to 2012-01-31	17,263	USD	276

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	-6,846	USD	276
2011-05-01 to 2012-01-31	-16,399	USD	276

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-05-01 to 2013-01-31	97,988	USD	276
2011-05-01 to 2012-01-31	-32,044	USD	276

Inspect the source

Entity: PHARMACYTE BIOTECH, INC. / CIK 0001157075
Captured: 2026-09-20T07:42:36.237Z
SEC response SHA-256: 8f9ad1662a11f3cb167c6975b558c6cce5e582ddebd7699a946a7cffe2a40413

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001157075.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))